A protein called NRF2 helps medulloblastoma cells resist chemo
Original title: NRF2 activation is required for chemotherapy resistance acquisition in medulloblastoma via metabolic and redox adaptation.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was only done with cells in the lab, not in people.
The short version
In lab tests, blocking one protein made tumor cells respond to chemo again.
What was studied. Researchers grew medulloblastoma cells in the lab that had become resistant to chemo. The drugs were vincristine: A chemotherapy given into a vein. It is the V in PCV. It can cause numbness or tingling in the hands and feet, which is worth reporting early. See the glossary, etoposide, cisplatin, and cyclophosphamide. Medulloblastoma is a fast growing brain tumor in children.
What they found. The resistant cells had stronger defenses against harmful molecules inside them. They held more glutathione and had more thioredoxin reductase activity. Both help cells handle stress. The cells also shifted how they used sugar to fuel those defenses. A protein called NRF2 was driving these changes. When the team blocked NRF2, the resistant cells responded to chemo again. Blocking it also kept other cells from turning resistant in the first place.
What this means, and what it doesn't
What it could mean: Chemo can stop working when tumor cells build up these inner defenses. This study points to NRF2 as one reason why. That makes NRF2 something scientists may try to target later.
What it doesn't mean: This work was done on cells in a dish, not in people. No child was treated in this study. There is no NRF2 drug a doctor can offer today. It does not mean chemo resistance is solved, and it is not a cure. Years of testing would come first.
Source: PubMed, September 3, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.